{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/www.drugpolicy.ca\/fr\/","author_name":"Affinity Bridge","author_url":"https:\/\/www.drugpolicy.ca\/fr\/author\/affinity-bridge\/","title":"R\u00e9duction des m\u00e9faits - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"RjSoKq2mO7\"><a href=\"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/\">R\u00e9duction des m\u00e9faits<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.drugpolicy.ca\/fr\/les-problemes\/reduction-des-mefaits\/embed\/#?secret=RjSoKq2mO7\" width=\"600\" height=\"338\" title=\"&#8220;R\u00e9duction des m\u00e9faits&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"RjSoKq2mO7\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Turning-Point-OPS-1.jpg","thumbnail_width":1200,"thumbnail_height":800,"description":"La r\u00e9duction des m\u00e9faits permet de sauver des vies et de mettre les gens en contact avec un soutien social vital, des services et des traitements fond\u00e9s sur des donn\u00e9es probantes. Qu&#8217;est-ce que la r\u00e9duction des m\u00e9faits ? La r\u00e9duction des risques est une approche philosophique de la consommation de drogues. Elle reconna\u00eet la complexit\u00e9 [&hellip;]"}